Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.21.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Beginning balance, value at Dec. 31, 2019 $ 836,000 $ 664,064,000 $ (486,470,000) $ 178,430,000
Beginning balance, shares at Dec. 31, 2019 83,622,135        
Stock option-based compensation expense 4,083,000 4,083,000
Restricted stock-based compensation expense 812,000 812,000
Common stock issued for cash exercise of options $ 1,000 174,000 175,000
Common stock issued for cash exercise of options, shares 75,793        
Issuance of common stock in connection with restricted share awards $ 8,000 (8,000)
Issuance of common stock in connection with restricted share awards, shares 818,233        
Net loss (68,406,000) (68,406,000)
Other comprehensive income (loss) 17,000 17,000
Ending balance, value at Sep. 30, 2020 $ 845,000 669,125,000 (554,876,000) 17,000 115,111,000
Ending balance, shares at Sep. 30, 2020 84,516,161        
Beginning balance, value at Jun. 30, 2020 $ 848,000 667,712,000 (547,639,000) 133,000 121,054,000
Beginning balance, shares at Jun. 30, 2020 84,781,241        
Stock option-based compensation expense 1,249,000 1,249,000
Restricted stock-based compensation expense 161,000 161,000
Cancellation of restricted share awards $ (3,000) 3,000
Cancellation of restricted share awards, shares (265,080)        
Net loss (7,237,000) (7,237,000)
Other comprehensive income (loss) (116,000) (116,000)
Ending balance, value at Sep. 30, 2020 $ 845,000 669,125,000 (554,876,000) 17,000 115,111,000
Ending balance, shares at Sep. 30, 2020 84,516,161        
Beginning balance, value at Dec. 31, 2020 $ 961,000 672,304,000 (570,704,000) (10,000) 102,551,000
Beginning balance, shares at Dec. 31, 2020 96,131,678        
Stock option-based compensation expense 3,797,000 3,797,000
Restricted stock-based compensation expense 3,118,000 3,118,000
Common stock issued for cash exercise of options $ 6,000 825,000 831,000
Common stock issued for cash exercise of options, shares 630,675        
Issuance of common stock in connection with restricted share awards $ 20,000 (20,000)
Issuance of common stock in connection with restricted share awards, shares 2,021,900        
Common stock issued for cash under open market sale agreement $ 32,000 7,667,000 7,699,000
Common stock issued for cash under open market sale agreement, shares 3,083,286        
Net loss (38,253,000) (38,253,000)
Other comprehensive income (loss) 1,000 1,000
Ending balance, value at Sep. 30, 2021 $ 1,019,000 687,691,000 (608,957,000) (9,000) $ 79,744,000
Ending balance, shares at Sep. 30, 2021 101,867,539       101,867,539
Beginning balance, value at Jun. 30, 2021 $ 1,013,000 684,987,000 (601,913,000) (1,000) $ 84,086,000
Beginning balance, shares at Jun. 30, 2021 101,251,023        
Stock option-based compensation expense 1,387,000 1,387,000
Restricted stock-based compensation expense 1,150,000 1,150,000
Common stock issued for cash exercise of options $ 1,000 139,000 140,000
Common stock issued for cash exercise of options, shares 121,950        
Issuance of common stock in connection with restricted share awards $ 5,000 (5,000)
Issuance of common stock in connection with restricted share awards, shares 474,825        
Common stock issued for cash under open market sale agreement 33,000 33,000
Common stock issued for cash under open market sale agreement, shares 19,741        
Net loss (7,044,000) (7,044,000)
Other comprehensive income (loss) (8,000) (8,000)
Ending balance, value at Sep. 30, 2021 $ 1,019,000 $ 687,691,000 $ (608,957,000) $ (9,000) $ 79,744,000
Ending balance, shares at Sep. 30, 2021 101,867,539       101,867,539